Biomarkers in Prediction of AMI
Not Applicable
Recruiting
- Conditions
- Acute Mesenteric Ischemia
- Interventions
- Diagnostic Test: Sequential blood samples
- Registration Number
- NCT06212921
- Lead Sponsor
- University of Tartu
- Brief Summary
Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- Age 18 years or older
- Initial decision in favour of further diagnostics of mesenteric ischaemia
Exclusion Criteria
- Age <18 years
- Consent declined by patient or next of kin (delayed consent)
- Chronic mesenteric ischaemia without an acute event
- Immediate decision for withdrawal of further diagnostics and active treatment
- Referral from another hospital with already established diagnosis of AMI
- AMI diagnosed at surgery without previously having been considered
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Patient with suspicion of acute mesenteric ischaemia Sequential blood samples Bolld samples is the only intervention. All patients with suspicion of AMI will be included and blood samples collected
- Primary Outcome Measures
Name Time Method Rate of correctly predicted cases of acute mesenteric ischaemia 10 months Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Tartu University Hospital
🇪🇪Tartu, Estonia
Lucerne Cantonal Hospital
🇨🇭Luzern, Switzerland